Zurich Insurance plans to invest around Rs 4,051 crore to buy a 51% stake in Kotak General Insurance through a mix of fresh capital and share purchase. The deal also gives Zurich an option to acquire an additional 19% within three years, potentially tightening its grip on the insurer’s future direction.
Sun Pharmaceutical has made a bold $13 billion bid for US firm Organon & Co., signaling its biggest push to shift from generics toward branded and innovative medicines. Sun is competing with other bidders for Organon, and a successful deal would effectively merge Organon into Sun Pharma, reshaping its global ambitions.
Your news, in seconds
Get the Beige app — every story in 60 words, updated hourly. Free on iOS & Android.
Swipe through stories, personalise your feed, and save articles for later — all on the app.
